İstanbul Journal of Pharmacy

SUBMITINFORMATION
EnglishTürkçe

Research Article


DOI :10.26650/IstanbulJPharm.2021.835751   IUP :10.26650/IstanbulJPharm.2021.835751    Full Text (PDF)

Clinical pharmacist directed anticoagulation monitoring services: a prospective ınterventional study

Anusree Sarika, Anupama Reghu, Mohammed Salim Karattuthodi, Aravind Ramakrishna Pillai Sreelatha

Background and Aims: Antithrombotic therapies are established as cornerstones of treatment for a wide variety of ischemic vascular diseases. The study aimed to develop clinical pharmacist directed anticoagulation monitoring services in the cardiology department at tertiary care referral super specialty hospital. Method: Prospective interventional study was conducted for 12 months in the cardiology inpatient setting of a private tertiary care referral hospital in the Malabar region of Kerala. Constituted to be in three phases, they are: assessment of the present anticoagulation related practices, the development and sharing of anticoagulation protocol and finally the intervention and implementation of the system. Results and Discussion: Monitoring of the treatment could enhance the drug selection approaches, improved adherence to clinical guidelines and health outcomes. Heparin was the commonly prescribed drug in the cardiology department which had the risk of thrombocytopenia and major bleed, whereas this risk was lesser with fondaparinux. Early detection of bleeding could prevent complications from happening to the patients. The collaboration of the clinical pharmacist into anticoagulation therapy influenced the physician to comply with the ACCP guideline. Conclusion: The clinical pharmacist directed anticoagulation monitoring services improved the overall medical status of the patient.

Keywords: ACCP, Anticoagulation, Clinical Pharmacist, Guideline Compliance, Management service, Medication Error

PDF View

References

  • Ahmed, I., Majeed, A., & Powell, R. (2007). Heparin induced throm-bocytopenia: Diagnosis and management update. Postgradu-ate Medical Journal, 83(983), 575-582. https://doi.org/10.1136/ pgmj.2007.059188 google scholar
  • Akesson, A., Larsson, S. C., Discacciati, A., & Wolk, A. (2014). Low-risk diet and lifestyle habits in the primary prevention of myo-cardial infarction in men: A population-based prospective cohort study. Journal of the American College of Cardiology, 64(13), 12991306. https://doi.org/10.1016/j.jacc.2014.06.1190 google scholar
  • Bauer, K. A. (2001). Fondaparinux sodium: A selective inhibitor of factor Xa. American Journal of Health-System Pharmacy: AJHP: Of-ficial Journal of the American Society of Health-System Pharmacists, 58 Suppl 2, S14-17. https://doi.org/10.1093/ajhp/58.suppl_2.S14 Coussement, P. K., Bassand, J. P., Convens, C., Vrolix, M., Boland, J., Grollier, G., ... PENTALYSE investigators. (2001). A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrino-lysis in acute myocardial infarction. The PENTALYSE study. Euro-pean Heart Journal, 22(18), 1716-1724. https://doi.org/10.1053/ euhj.2001.2777 google scholar
  • Hajj, I., Al-Masri, M., Bashaireh, K., Hani, M. B., Hamouri, S., Khou-zami, J., . Fadel, C. (2021). A cross-sectional, multicenter, obser-vational study to assess the prophylaxis of venous thromboem-bolism in Lebanese and Jordanian hospitals. Thrombosis Journal, 19(1), 9. https://doi.org/10.1186/s12959-021-00261-2 google scholar
  • Henriksen, J. N., Nielsen, L. P., Hellebek, A., & Poulsen, B. K. (2017). Medication errors involving anticoagulants: Data from the Dan-ish patient safety database. Pharmacology Research & Perspectives, 5(3), e00307. https://doi.org/10.1002/prp2.307 google scholar
  • Kolhatkar, A., Cheng, L., Chan, F. K. I., Harrison, M., & Law, M. R. (2016). The impact of medication reviews by community phar-macists. Journal of the American Pharmacists Association: JAPhA, 56(5), 513-520.e1. https://doi.org/10.1016/j.japh.2016.05.002 Kollias, A., Kyriakoulis, K. G., Dimakakos, E., Poulakou, G., Stergiou, G. S., & Syrigos, K. (2020). Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for ac-tion. British Journal of Haematology, 189(5), 846-847. google scholar
  • Lakshminarayan, K., Solid, C. A., Collins, A. J., Anderson, D. C., & Herzog, C. A. (2006). Atrial fibrillation and stroke in the general medicare population: A 10-year perspective (1992 to 2002). Stroke, 37(8), 1969-1974. https://doi.org/10.1161/01. STR.0000230607.07928.17 google scholar
  • Mamdani, M. M., Racine, E., McCreadie, S., Zimmerman, C., O’Sullivan, T. L., Jensen, G., . Stevenson, J. G. (1999). Clinical and economic effectiveness of an inpatient anticoagulation service. Pharmacotherapy, 19(9), 1064-1074. https://doi.org/10.1592/ phco.19.13.1064.31591 google scholar
  • Mosca, L., Barrett-Connor, E., & Wenger, N. K. (2011). Sex/gender differences in cardiovascular disease prevention: What a differ-ence a decade makes. Circulation, 124(19), 2145-2154. https:// doi.org/10.1161/CIRCULATIONAHA.110.968792 google scholar
  • Piazza, G., Nguyen, T. N., Cios, D., Labreche, M., Hohlfelder, B., Fan-ikos, J., . Goldhaber, S. Z. (2011). Anticoagulation-associated adverse drug events. The American Journal of Medicine, 124(12), 1136-1142. https://doi.org/10.1016/j.amjmed.2011.06.009 Pranckeviciene, G., Kadusevicius, E., & Putniene, A. (2013). Influ-ence of coadministration of antithrombotic medicines, warfarin, and NSAIDs on heparin safety: Data from a prospective obser-vational study. Journal of Managed Care Pharmacy: JMCP, 19(6), 478-486. https://doi.org/10.18553/jmcp.2013.19.6.478 google scholar
  • Reddy, T., Prasad T S, D., Swetha, S., Nirmala, G., & Ram, P. (2018). A study on antiplatelets and anticoagulants utilisation in a tertiary care hospital. International Journal of Pharmaceutical and Clinical Research, 10, 155-161. google scholar
  • Roberts, L. N., Patel, R. K., & Arya, R. (2009). Venous thromboembo-lism and ethnicity. British Journal of Haematology, 146(4), 369-383. https://doi.org/10.1111/j.1365-2141.2009.07786.x google scholar
  • Schillig, J., Kaatz, S., Hudson, M., Krol, G. D., Szandzik, E. G., & Kalus, J. S. (2011). Clinical and safety impact of an inpatient pharmacist-directed anticoagulation service. Journal of Hospital Medicine, 6(6), 322-328. https://doi.org/10.1002/jhm.910 google scholar
  • Schumock, G. T., Butler, M. G., Meek, P. D., Vermeulen, L. C., Arondekar, B. V., Bauman, J. L., & 2002 Task Force on Economic Evaluation of Clinical Pharmacy Services of the American College of Clinical Pharmacy. (2003). Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy, 23(1), 113-132. https://doi.org/10.1592/phco.23.1.113.31910 google scholar
  • Sharma, M., Krishnamurthy, M., Snyder, R., & Mauro, J. (2017). Re-ducing Error in Anticoagulant Dosing via Multidisciplinary Team Rounding at Point of Care. Clinics and Practice, 7(2), 953. https:// doi.org/10.4081/cp.2017.953 google scholar
  • Talon, B., Perez, A., Yan, C., Alobaidi, A., Zhang, K. H., Schultz, B. G., ... Touchette, D. R. (2020). Economic evaluations of clinical phar-macy services in the United States: 2011-2017. JACCP: Journal Of The American College of Clinical Pharmacy, 3(4), 793-806. https:// doi.org/10.1002/jac5.1199 google scholar
  • Tariq, R. A., Vashisht, R., Sinha, A., & Scherbak, Y. (2021). Medication Dispensing Errors And Prevention. In StatPearls. Treasure Island (FL): StatPearls Publishing. Retrieved from http://www.ncbi.nlm. nih.gov/books/NBK519065/ google scholar
  • Thompson, L. E., Maddox, T. M., Lei, L., Grunwald, G. K., Bradley, S. M., Peterson, P. N., . Daugherty, S. L. (2017). Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR®) PIN-NACLE Registry. Journal of the American Heart Association, 6(7), e005801. https://doi.org/10.1161/JAHA.117.005801 google scholar
  • Yau, J. W., Stafford, A. R., Liao, P., Fredenburgh, J. C., Roberts, R., & Weitz, J. I. (2011). Mechanism of catheter thrombosis: Comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. Blood, 118(25), 6667-6674. https:// doi.org/10.1182/blood-2011-07-364141 google scholar
  • Yu, H.-T., Dylan, M. L., Lin, J., & Dubois, R. W. (2007). Hospitals’ com-pliance with prophylaxis guidelines for venous thromboembo-lism. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists, 64(1), 69-76. https://doi.org/10.2146/ajhp060115 google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Sarika, A., Reghu, A., Karattuthodi, M.S., & Pillai Sreelatha, A.R. (2021). Clinical pharmacist directed anticoagulation monitoring services: a prospective ınterventional study. İstanbul Journal of Pharmacy, 51(3), 291-298. https://doi.org/10.26650/IstanbulJPharm.2021.835751


AMA

Sarika A, Reghu A, Karattuthodi M S, Pillai Sreelatha A R. Clinical pharmacist directed anticoagulation monitoring services: a prospective ınterventional study. İstanbul Journal of Pharmacy. 2021;51(3):291-298. https://doi.org/10.26650/IstanbulJPharm.2021.835751


ABNT

Sarika, A.; Reghu, A.; Karattuthodi, M.S.; Pillai Sreelatha, A.R. Clinical pharmacist directed anticoagulation monitoring services: a prospective ınterventional study. İstanbul Journal of Pharmacy, [Publisher Location], v. 51, n. 3, p. 291-298, 2021.


Chicago: Author-Date Style

Sarika, Anusree, and Anupama Reghu and Mohammed Salim Karattuthodi and Aravind Ramakrishna Pillai Sreelatha. 2021. “Clinical pharmacist directed anticoagulation monitoring services: a prospective ınterventional study.” İstanbul Journal of Pharmacy 51, no. 3: 291-298. https://doi.org/10.26650/IstanbulJPharm.2021.835751


Chicago: Humanities Style

Sarika, Anusree, and Anupama Reghu and Mohammed Salim Karattuthodi and Aravind Ramakrishna Pillai Sreelatha. “Clinical pharmacist directed anticoagulation monitoring services: a prospective ınterventional study.” İstanbul Journal of Pharmacy 51, no. 3 (Jul. 2024): 291-298. https://doi.org/10.26650/IstanbulJPharm.2021.835751


Harvard: Australian Style

Sarika, A & Reghu, A & Karattuthodi, MS & Pillai Sreelatha, AR 2021, 'Clinical pharmacist directed anticoagulation monitoring services: a prospective ınterventional study', İstanbul Journal of Pharmacy, vol. 51, no. 3, pp. 291-298, viewed 2 Jul. 2024, https://doi.org/10.26650/IstanbulJPharm.2021.835751


Harvard: Author-Date Style

Sarika, A. and Reghu, A. and Karattuthodi, M.S. and Pillai Sreelatha, A.R. (2021) ‘Clinical pharmacist directed anticoagulation monitoring services: a prospective ınterventional study’, İstanbul Journal of Pharmacy, 51(3), pp. 291-298. https://doi.org/10.26650/IstanbulJPharm.2021.835751 (2 Jul. 2024).


MLA

Sarika, Anusree, and Anupama Reghu and Mohammed Salim Karattuthodi and Aravind Ramakrishna Pillai Sreelatha. “Clinical pharmacist directed anticoagulation monitoring services: a prospective ınterventional study.” İstanbul Journal of Pharmacy, vol. 51, no. 3, 2021, pp. 291-298. [Database Container], https://doi.org/10.26650/IstanbulJPharm.2021.835751


Vancouver

Sarika A, Reghu A, Karattuthodi MS, Pillai Sreelatha AR. Clinical pharmacist directed anticoagulation monitoring services: a prospective ınterventional study. İstanbul Journal of Pharmacy [Internet]. 2 Jul. 2024 [cited 2 Jul. 2024];51(3):291-298. Available from: https://doi.org/10.26650/IstanbulJPharm.2021.835751 doi: 10.26650/IstanbulJPharm.2021.835751


ISNAD

Sarika, Anusree - Reghu, Anupama - Karattuthodi, MohammedSalim - Pillai Sreelatha, AravindRamakrishna. “Clinical pharmacist directed anticoagulation monitoring services: a prospective ınterventional study”. İstanbul Journal of Pharmacy 51/3 (Jul. 2024): 291-298. https://doi.org/10.26650/IstanbulJPharm.2021.835751



TIMELINE


Submitted05.12.2020
Accepted19.05.2021
Published Online09.12.2021

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.